Interruption of OX40L signaling prevents costimulation blockade–resistant allograft rejection-Reference-Cited by-同舟云学术

Interruption of OX40L signaling prevents costimulation blockade–resistant allograft rejection

Published:2017-03-09 Issue:5 Volume:2 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Kitchens William H.,Dong Ying,Mathews David V.,Breeden Cynthia P.,Strobert Elizabeth,Fuentes Maria E.,Larsen Christian P.,Ford Mandy L.,Adams Andrew B.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference28 articles.

1. Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

2. A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

3. Belatacept and Long-Term Outcomes in Kidney Transplantation

4. Five-Year Safety and Efficacy of Belatacept in Renal Transplantation

5. Primed Allospecific T Cells Prevent the Effects of Costimulatory Blockade on Prolonged Cardiac Allograft Survival in Mice

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection;Immunology Letters;2024-06

2. Clinical application of immune repertoire sequencing in solid organ transplant;Frontiers in Immunology;2023-02-14

3. Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells;Signal Transduction and Targeted Therapy;2022-03-18

4. Prolongation of allograft survival by artemisinin treatment is associated with blockade of OX40-OX40L;Immunopharmacology and Immunotoxicology;2021-03-24

5. Multi-modal Network Representation Learning;Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining;2020-07-06